Fund profile
Tickers
JAGLX, JFNAX, JFNCX, JFNIX, JFNSX, JNGLX, JFNNX
Fund manager
Total assets
$4.93 bn
Liabilities
$27.83 mm
Net assets
$4.90 bn
Number of holdings
122.00
122 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
UNH Unitedhealth Group Inc | 317.26 mm | 602.61 k shares | 6.47 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 251.79 mm | 431.95 k shares | 5.13 | Common equity | Long | USA |
Novo Nordisk A/S - Class B
|
205.86 mm | 1.99 mm shares | 4.20 | Common equity | Long | Denmark |
AZN Astrazeneca plc | 193.74 mm | 1.43 mm shares | 3.95 | Common equity | Long | UK |
MRK Merck & Co Inc | 153.26 mm | 1.41 mm shares | 3.13 | Common equity | Long | USA |
ABT Abbott Laboratories | 130.28 mm | 1.18 mm shares | 2.66 | Common equity | Long | USA |
Sanofi
|
130.02 mm | 1.31 mm shares | 2.65 | Common equity | Long | France |
ABBV Abbvie Inc | 128.12 mm | 826.77 k shares | 2.61 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 115.66 mm | 284.25 k shares | 2.36 | Common equity | Long | USA |
NVS Novartis AG | 114.38 mm | 1.13 mm shares | 2.33 | Long | USA | |
BSX Boston Scientific Corp. | 108.23 mm | 1.87 mm shares | 2.21 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 101.22 mm | 190.69 k shares | 2.06 | Common equity | Long | USA |
DHR Danaher Corp. | 90.77 mm | 392.36 k shares | 1.85 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 88.66 mm | 919.47 k shares | 1.81 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 83.02 mm | 2.80 mm shares | 1.69 | Common equity | Long | USA |
ELV Elevance Health Inc | 80.29 mm | 170.27 k shares | 1.64 | Common equity | Long | USA |
SYK Stryker Corp. | 77.42 mm | 258.53 k shares | 1.58 | Common equity | Long | USA |
Roche Holding AG
|
75.91 mm | 261.06 k shares | 1.55 | Common equity | Long | Switzerland |
CYTK Cytokinetics Inc | 74.98 mm | 898.10 k shares | 1.53 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 74.74 mm | 323.03 k shares | 1.52 | Common equity | Long | USA |
AMGN AMGEN Inc. | 73.90 mm | 256.59 k shares | 1.51 | Common equity | Long | USA |
ARGX Argen X SE | 73.89 mm | 194.23 k shares | 1.51 | Long | USA | |
ASND Ascendis Pharma A/S | 71.32 mm | 566.23 k shares | 1.45 | Long | USA | |
COR Cencora Inc. | 69.85 mm | 340.11 k shares | 1.42 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 63.04 mm | 826.75 k shares | 1.28 | Common equity | Long | USA |
ISRG Intuitive Surgical Inc | 61.06 mm | 180.98 k shares | 1.25 | Common equity | Long | USA |
HUM Humana Inc. | 59.14 mm | 129.19 k shares | 1.21 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 58.62 mm | 933.38 k shares | 1.20 | Common equity | Long | USA |
HCA HCA Healthcare Inc | 57.40 mm | 212.07 k shares | 1.17 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 52.41 mm | 265.55 k shares | 1.07 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 51.05 mm | 387.43 k shares | 1.04 | Common equity | Long | USA |
Janus Henderson Cash Liquidity Fund
|
50.88 mm | 50.87 mm shares | 1.04 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 48.36 mm | 1.13 mm shares | 0.99 | Common equity | Long | USA |
CNC Centene Corp. | 47.11 mm | 634.88 k shares | 0.96 | Common equity | Long | USA |
GMED Globus Medical Inc - Ordinary Shares | 46.84 mm | 879.01 k shares | 0.95 | Common equity | Long | USA |
COO Cooper Companies, Inc. | 43.63 mm | 115.29 k shares | 0.89 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 43.35 mm | 197.13 k shares | 0.88 | Common equity | Long | USA |
TFX Teleflex Incorporated | 41.89 mm | 168.02 k shares | 0.85 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 40.98 mm | 2.90 mm shares | 0.83 | Long | USA | |
LNTH Lantheus Holdings Inc | 40.31 mm | 650.08 k shares | 0.82 | Common equity | Long | USA |
ILMN Illumina Inc | 39.94 mm | 286.84 k shares | 0.81 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 39.10 mm | 405.48 k shares | 0.80 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 38.11 mm | 1.61 mm shares | 0.78 | Common equity | Long | USA |
JNJ Johnson & Johnson | 37.72 mm | 240.62 k shares | 0.77 | Common equity | Long | USA |
Zai Lab Ltd (ADR) | 36.32 mm | 1.33 mm shares | 0.74 | Long | USA | |
MDT Medtronic Plc | 34.74 mm | 421.71 k shares | 0.71 | Common equity | Long | USA |
STE Steris Plc | 34.53 mm | 157.06 k shares | 0.70 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 34.14 mm | 1.46 mm shares | 0.70 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 33.58 mm | 38.24 k shares | 0.69 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 32.36 mm | 2.28 mm shares | 0.66 | Common equity | Long | USA |
Astellas Pharma Inc
|
32.12 mm | 2.69 mm shares | 0.66 | Common equity | Long | Japan |
ARDX Ardelyx Inc | 30.67 mm | 4.95 mm shares | 0.63 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 30.57 mm | 508.10 k shares | 0.62 | Long | USA | |
BAX Baxter International Inc. | 29.94 mm | 774.48 k shares | 0.61 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 28.74 mm | 1.04 mm shares | 0.59 | Common equity | Long | USA |
DXCM Dexcom Inc | 28.19 mm | 227.20 k shares | 0.57 | Common equity | Long | USA |
PEN Penumbra Inc | 26.81 mm | 106.60 k shares | 0.55 | Common equity | Long | USA |
ACLX Arcellx Inc | 26.32 mm | 474.25 k shares | 0.54 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 25.64 mm | 720.59 k shares | 0.52 | Common equity | Long | USA |
Hoya Corp
|
24.35 mm | 194.80 k shares | 0.50 | Common equity | Long | Japan |
CTLT Catalent Inc. | 23.33 mm | 519.36 k shares | 0.48 | Common equity | Long | USA |
ICLR Icon Plc | 23.29 mm | 82.29 k shares | 0.47 | Common equity | Long | USA |
ETNB 89bio Inc | 22.90 mm | 2.05 mm shares | 0.47 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 22.90 mm | 815.19 k shares | 0.47 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 22.86 mm | 282.23 k shares | 0.47 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 21.55 mm | 112.56 k shares | 0.44 | Common equity | Long | USA |
NEW HORIZON HEALTH LTD
|
21.45 mm | 7.24 mm shares | 0.44 | Common equity | Long | Hong Kong |
PRTA Prothena Corporation plc | 21.21 mm | 583.76 k shares | 0.43 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 20.80 mm | 1.03 mm shares | 0.42 | Common equity | Long | USA |
XRAY DENTSPLY Sirona Inc | 19.55 mm | 549.39 k shares | 0.40 | Common equity | Long | USA |
TNDM Tandem Diabetes Care Inc | 19.59 mm | 662.29 k shares | 0.40 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 19.48 mm | 71.11 k shares | 0.40 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 19.39 mm | 676.10 k shares | 0.40 | Common equity | Long | USA |
Takeda Pharmaceutical Co Ltd
|
18.47 mm | 642.34 k shares | 0.38 | Common equity | Long | Japan |
NEO Neogenomics Inc. | 15.44 mm | 954.02 k shares | 0.32 | Common equity | Long | USA |
ABMD Abiomed Inc | 15.31 mm | 80.36 k shares | 0.31 | Common equity | Long | USA |
Bridgebio Pharma Inc
|
14.36 mm | 355.70 k shares | 0.29 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 14.33 mm | 485.55 k shares | 0.29 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 13.99 mm | 60.47 k shares | 0.28 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 13.38 mm | 291.07 k shares | 0.27 | Common equity | Long | USA |
CRGX CARGO Therapeutics Inc | 13.28 mm | 573.59 k shares | 0.27 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 13.18 mm | 323.39 k shares | 0.27 | Long | USA | |
XENE Xenon Pharmaceuticals Inc | 11.99 mm | 260.35 k shares | 0.24 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 11.85 mm | 165.51 k shares | 0.24 | Common equity | Long | USA |
SLNO Soleno Therapeutics Inc | 11.31 mm | 281.10 k shares | 0.23 | Common equity | Long | USA |
INSM Insmed Inc | 10.26 mm | 331.01 k shares | 0.21 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 9.20 mm | 298.75 k shares | 0.19 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 8.18 mm | 563.57 k shares | 0.17 | Common equity | Long | USA |
IRON Disc Medicine Inc | 7.02 mm | 121.58 k shares | 0.14 | Common equity | Long | USA |
Element Biosciences Inc | 6.55 mm | 425.02 k shares | 0.13 | Preferred equity | Long | USA |
ICUI ICU Medical, Inc. | 6.53 mm | 65.47 k shares | 0.13 | Common equity | Long | USA |
Janus Henderson Cash Collateral Fund
|
6.06 mm | 6.06 mm shares | 0.12 | Common equity | Long | USA |
JANX Janux Therapeutics Inc | 5.99 mm | 557.86 k shares | 0.12 | Common equity | Long | USA |
Synthekine Inc | 5.66 mm | 2.19 mm shares | 0.12 | Preferred equity | Long | USA |
Bicara Therapeutics - Series C | 5.58 mm | 4.05 mm shares | 0.11 | Preferred equity | Long | USA |
Heartflow Inc | 5.51 mm | 1.93 mm shares | 0.11 | Preferred equity | Long | USA |
Curevo Inc | 5.20 mm | 2.03 mm shares | 0.11 | Preferred equity | Long | USA |
Attralus Inc | 5.20 mm | 669.94 k shares | 0.11 | Preferred equity | Long | USA |
Shoreline Biosciences Inc | 4.89 mm | 747.19 k shares | 0.10 | Preferred equity | Long | USA |
LEXEO Therapeutics Inc - Series A
|
4.62 mm | 343.93 k shares | 0.09 | Common equity | Long | USA |
LXEO Lexeo Therapeutics Inc. | 4.13 mm | 307.79 k shares | 0.08 | Common equity | Long | USA |
Sonoma Biotherapeutics Inc - Series B | 3.95 mm | 1.26 mm shares | 0.08 | Preferred equity | Long | USA |
Acelyrin Inc. Common Shares
|
3.74 mm | 501.41 k shares | 0.08 | Common equity | Long | USA |
Magnolia Medical Technologies Inc | 3.09 mm | 1.82 mm shares | 0.06 | Preferred equity | Long | USA |
Freenome Holdings Inc - Series D | 2.75 mm | 342.80 k shares | 0.06 | Preferred equity | Long | USA |
Freenome Holdings Inc - Series C | 2.71 mm | 337.47 k shares | 0.06 | Preferred equity | Long | USA |
Neurogene Inc - Series B | 2.48 mm | 127.90 k shares | 0.05 | Preferred equity | Long | USA |
Neurogene Inc | 2.44 mm | 126.00 k shares | 0.05 | Preferred equity | Long | USA |
Neurogene Inc | 2.23 mm | 114.96 k shares | 0.04 | Preferred equity | Long | USA |
Sonoma Biotherapeutics Series B Preferred Stock | 2.11 mm | 669.43 k shares | 0.04 | Preferred equity | Long | USA |
HemoShear Therapeutics LLC | 2.08 mm | 289.28 k shares | 0.04 | Preferred equity | Long | USA |
Arbor Biotechnologies Inc | 1.80 mm | 156.43 k shares | 0.04 | Preferred equity | Long | USA |
Asher Biotherapeutics Inc | 1.83 mm | 1.21 mm shares | 0.04 | Preferred equity | Long | USA |
Royal Bank of Canada | 1.52 mm | 1.52 mm principal | 0.03 | Short-term investment vehicle | Long | USA |
TwinStrand Biosciences Inc | 1.38 mm | 344.31 k shares | 0.03 | Preferred equity | Long | USA |
LEXEO Therapeutics Inc - Series B
|
1.30 mm | 97.01 k shares | 0.03 | Common equity | Long | USA |
Hemoshear Therapeutics LLC | 558.00 k | 558.00 k principal | 0.01 | Debt | Long | USA |
Acelyrin Inc. Indemnity Holdback Shares
|
340.90 k | 60.93 k shares | 0.01 | Common equity | Long | USA |
Magnolia Medical Technologies Series D 10% | 192.25 k | 192.25 k principal | 0.00 | Debt | Long | USA |
Leap Therapeutics Inc. Indemnity Holdback shares | 147.67 k | 47.50 k shares | 0.00 | Preferred equity | Long | USA |
Magnolia Medical Technologies Inc
|
0 | 1.00 shares | 0.00 | Common equity | Long | USA |
Clementia Pharmaceuticals Inc CVR | 1.00 | 874.31 k shares | 0.00 | Long | USA |